pubrio
Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) logo

Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development)

Privately Held
microsize.com
制药行业28 employeesFounded 1994🇺🇸 美国

Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.

成立年份
1994
员工人数
28
行业
制药行业
公司类型
Privately Held
总部
🇺🇸20 Pacific Dr, Quakertown, Pennsylvania 18951, US (+1)
专长
制药行业

扩张情报

全新 · 仅在 Pubrio

我们正在追踪 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的市场扩张

全球扩张

实时
阶段
探索中投入中进入中运营中
了解一下

关于 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的常见问题

关于 Microsize (Micronization, Particle Size Engineering, Pharmaceutical Development) 的业务、市场和增长信号的快速解答。

Microsize is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in the US. The company specializes in micronization, particle size engineering, and pharmaceutical development, focusing on enhancing the solubility and bioavailability of Active Pharmaceutical Ingredients (APIs). With the largest micronization business in North America, Microsize operates over 100,000 square feet of FDA-inspected facilities near Philadelphia, which include R&D centers, analytical labs, and GMP manufacturing suites. Microsize offers a range of core services, including micronization and milling for particle size reduction, particle classification for precise size distribution, and analytical characterization to support quality control. The company is equipped to handle highly potent active pharmaceutical ingredients (HPAPIs) with advanced containment technologies. With nearly three decades of experience, Microsize has processed hundreds of small molecule APIs and pharmaceutical excipients, serving a diverse customer base from biotech startups to large pharmaceutical companies. The leadership team brings extensive expertise in drug development and manufacturing, making Microsize a reliable partner in the pharmaceutical industry.

今天就开启旅程

可以先用平台,也可以先聊聊

你可以自行使用 Pubrio,或让我们的团队协助研究、获客或数据整合。

与团队沟通
Start Journey Image
pubrio

Pubrio 将来自 50+ 本地来源的商业、人物与意向数据整合为全球图谱,帮助 AI 与营收团队洞悉全市场。

© 2026 Pubrio。保留所有权利。